Literature DB >> 18413566

Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P.

Y Kawai1, M Suenaga, A Takeda, M Ito, H Watanabe, F Tanaka, K Kato, H Fukatsu, S Naganawa, T Kato, K Ito, G Sobue.   

Abstract

OBJECTIVE: We evaluated comprehensive neuropsychological tests and regional brain blood flow to compare cognitive dysfunction between two types of multiple system atrophy: predominant cerebellar ataxia (MSA-C) and predominant parkinsonism (MSA-P).
METHODS: Twenty-one patients with MSA-C, 14 patients with MSA-P, and 21 age- and education-matched control subjects were subjected to neuropsychological tests and SPECT. The neuropsychological tests examined general cognition, verbal and visual memory, working memory, visuospatial and constructional ability, language, executive function, depression, and anxiety, while SPECT analysis examined brain perfusion.
RESULTS: Patients with MSA-P showed severe involvement of visuospatial and constructional function, verbal fluency, and executive function compared with control subjects. Patients with MSA-C showed involvement only in visuospatial and constructional function compared with control subjects and a milder degree of involvement compared with patients with MSA-P. Patients with MSA-P tended toward a wide and severe impairment in cognitive function compared with patients with MSA-C. In addition, neuropsychological impairment in patients with MSA-P was significantly correlated with a decrease in prefrontal perfusion. This significant relation was not correlated to other factors such as age, education, and severity of cerebellar ataxia and parkinsonism, which are relevant factors associated with cognitive performance.
CONCLUSIONS: Patients with multiple system atrophy-parkinsonism show more severe and more widespread cognitive dysfunctions than patients with multiple system atrophy-cerebellar ataxia. Our results also indicate that cognitive dysfunction in patients with multiple system atrophy-parkinsonism may be associated with prefrontal involvement.

Entities:  

Mesh:

Year:  2008        PMID: 18413566     DOI: 10.1212/01.wnl.0000310413.04462.6a

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  50 in total

Review 1.  Gender differences in Parkinson's disease: clinical characteristics and cognition.

Authors:  Ivy N Miller; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2010-12-15       Impact factor: 10.338

2.  Cognitive impairment and structural brain damage in multiple system atrophy-parkinsonian variant.

Authors:  Francesca Caso; Elisa Canu; Milica Jecmenica Lukic; Igor N Petrovic; Andrea Fontana; Ivan Nikolic; Vladimir S Kostic; Massimo Filippi; Federica Agosta
Journal:  J Neurol       Date:  2019-09-26       Impact factor: 4.849

Review 3.  Diagnosis and differential diagnosis of MSA: boundary issues.

Authors:  Han-Joon Kim; Beom S Jeon; Kurt A Jellinger
Journal:  J Neurol       Date:  2015-02-07       Impact factor: 4.849

Review 4.  Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group.

Authors:  Iva Stankovic; Florian Krismer; Aleksandar Jesic; Angelo Antonini; Thomas Benke; Richard G Brown; David J Burn; Janice L Holton; Horacio Kaufmann; Vladimir S Kostic; Helen Ling; Wassilios G Meissner; Werner Poewe; Marija Semnic; Klaus Seppi; Atsushi Takeda; Daniel Weintraub; Gregor K Wenning
Journal:  Mov Disord       Date:  2014-04-18       Impact factor: 10.338

Review 5.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

Review 6.  Synucleinopathies: common features and hippocampal manifestations.

Authors:  Weiwei Yang; Shun Yu
Journal:  Cell Mol Life Sci       Date:  2016-11-08       Impact factor: 9.261

7.  Profile of cognitive impairment and underlying pathology in multiple system atrophy.

Authors:  Shunsuke Koga; Adam Parks; Ryan J Uitti; Jay A van Gerpen; William P Cheshire; Zbigniew K Wszolek; Dennis W Dickson
Journal:  Mov Disord       Date:  2016-11-15       Impact factor: 10.338

8.  Do selective serotonin reuptake inhibitors improve survival in multiple system atrophy?

Authors:  Elizabeth A Coon; J Eric Ahlskog; Michael H Silber; Robert D Fealey; Eduardo E Benarroch; Paola Sandroni; Jay N Mandrekar; Phillip A Low; Wolfgang Singer
Journal:  Parkinsonism Relat Disord       Date:  2017-12-14       Impact factor: 4.891

9.  Multiple system atrophy: current and future approaches to management.

Authors:  Olivier Flabeau; Wassilios G Meissner; François Tison
Journal:  Ther Adv Neurol Disord       Date:  2010-07       Impact factor: 6.570

10.  Cognition in multiple system atrophy: neuropsychological profile and interaction with mood.

Authors:  Meirav Balas; Yacov Balash; Nir Giladi; Tanya Gurevich
Journal:  J Neural Transm (Vienna)       Date:  2010-01-21       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.